Theranostics using 89Zr/177Lu-labeled antibody targeting erythropoietin-producing hepatocellular A2 (EphA2)
Tadashi Watabe(Osaka University), Kazunori Kato(Toyo University)
European Journal of Nuclear Medicine and Molecular Imaging
February 12, 2025
Cited by 6
Related Papers
Evaluation of Functional Connectivity in the Brain Using Positron Emission Tomography: A Mini-Review
|Frontiers in Neuroscience|2019|31
Evaluation of D-isomer of <sup>18</sup>F-FBPA for oncology PET focusing on the differentiation of glioma and inflammation.
|PubMed|2020|5
Serum EphA2 as a Promising Biomarker for the Early Detection and Diagnosis of Colorectal Cancer
|Biomolecules|2024|2
Difference of transport efflux in the rat C6 gliomas: comparative PET study between L and D-isomer of 11C-Methionine.
|Journal of Nuclear Medicine|2018|1
Ergothioneine Attenuates Oxaliplatin-Induced Peripheral Neuropathy Without Compromising Antitumor Efficacy
|International Journal of Molecular Sciences|2025|1